Effects of Neuromuscular Reeducation Versus Friction Massage in Lateral Epicondylitis
Effects of Neuromuscular Reeducation Versus Friction Massage in Lateral Epicondylitis: A Randomized Control Trial
Furqan Ahmed Siddiqi
42 participants
Jul 18, 2024
INTERVENTIONAL
Conditions
Summary
This study is a randomised control trial and the purpose of this study is to determine the effects of neuromuscular reeducation versus friction massage in lateral epicondylitis.
Eligibility
Inclusion Criteria4
- Diagnosed cases of lateral epicondylitis
- Age 25-50 years
- Both genders
- Postive tests; cozens, maudsley's, mills (at least any of 2)
Exclusion Criteria4
- Recent elbow fractures or dislocations
- Elbow joint instability
- Active joint disease
- Open wounds around elbow joints
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All participants will receive 4weeks of intervention with a frequency of 2-3 days/week with a period of rest in between. 5 minutes of ultrasound will be given followed by neuromuscular reeducation technique (5-10 minutes duration) which includes for the 1st two weeks; cross friction massage with active movement and for the last two weeks longitudinal friction massage with active movement will be performed and strengthening protocol will be given. The exercise protocol will be taught to the patient by an experienced physiotherapist and supervised on the subsequent sessions. The protocol will be gradually progressed as per the patient's tolerance.
All participants will receive 4weeks of intervention with a frequency of 2-3 days/week with a period of rest in between. 5 minutes of ultrasound will be given followed by friction massage technique(5-10 minutes duration) which includes for the 1st two weeks; cross friction massage alone and for the last two weeks longitudinal friction massage alone will be performed and strengthening protocol will be given. The exercise protocol will be taught to the patient by an experienced physiotherapist and supervised on the subsequent sessions. The protocol will be gradually progressed as per the patient's tolerance.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07004894